DGP IgA

If you have stubborn gut symptoms, unexplained anemia, or a family history of celiac disease, this antibody is one of the blood signals that can reveal whether gluten is triggering an immune attack on your small intestine. It measures your body's reaction to a specific, altered piece of gluten.

It is not usually the first celiac test doctors reach for, but it earns its place in specific situations: very young children, people whose main celiac antibody comes back negative despite real symptoms, and anyone checking whether a gluten-free diet is actually working. Knowing what it can and cannot tell you keeps you from over-reacting or under-reacting to the result.

What This Antibody Actually Is

DGP IgA (deamidated gliadin peptide immunoglobulin A antibody) is a protein your immune system makes to tag a specific target. That target is a short fragment of gluten (called gliadin) that has been chemically reshaped by an enzyme in the small intestine (tissue transglutaminase, often shortened to tTG). This reshaping, known as deamidation, makes the fragment far more provoking to the immune system.

In people who are genetically prone to celiac disease, these altered fragments drive the production of antibodies that then show up in the blood. The test measures the concentration of one class of these antibodies, called IgA. A separate test measures the IgG class, which behaves differently in some people, so the two are not interchangeable.

Celiac Disease

A high DGP IgA level reflects an active, gluten-driven immune reaction. When it appears alongside a high level of the standard celiac antibody (tTG IgA), it points strongly toward active celiac disease with flattening of the gut lining, the damage that causes malabsorption. On its own, the antibody signals the reaction rather than proving the diagnosis, which still rests on the full clinical picture.

The test performs well when suspicion is genuine. In adults with strong clinical suspicion, DGP IgA separated people with celiac disease from those without it nearly as well as the standard antibody. In one children's cohort, it caught roughly 92 of every 100 celiac cases and correctly cleared about 98 of every 100 people who did not have it, though pooled estimates across studies put DGP IgA sensitivity closer to 88 of 100.

Source: Niveloni et al. 2007 (adults); Lammi et al. 2015 (children); Novis et al. 2023 (platform comparison).

What this means for you: DGP IgA is a capable marker, but it usually does not beat the standard tTG antibody head to head. Its real value shows up in the specific situations below, not as a stand-alone screen.

Catching Cases the Standard Test Misses

The clearest reason to run this test is that the usual celiac antibody occasionally misses real disease. In older adults, adding DGP antibody testing has been reported to catch up to roughly 1 in 10 additional cases of biopsy-confirmed celiac disease that were negative on tTG IgA; in children the added yield is much smaller, around 2 percent. Most of this rescue effect comes from the IgG form of the DGP antibody rather than the IgA form, so the IgA test alone recovers fewer missed cases than the combined picture suggests.

In very young children, DGP antibodies also tend to appear earlier in the disease process, sometimes six to twelve months before the standard antibody turns positive. Much of this early-rise evidence comes from the IgG form of the antibody, a related but different measurement, so it does not translate directly to the IgA test in every case.

When a Positive Result Can Fool You

A positive DGP IgA is not the same as having celiac disease, and this is where the marker most often trips people up. When DGP is positive but the standard tTG antibody is normal, especially in someone at low risk, celiac disease often does not turn out to be present. In one low-risk pediatric screening study, only about 1 in 40 such cases was confirmed on biopsy, a positive predictive value (the share of positives that are true) of roughly 2.5 percent. In symptomatic or high-risk patients referred for evaluation, that figure is substantially higher, closer to 1 in 6, so the same result carries very different weight depending on who is tested.

The apparent contradiction resolves once you stop treating this as a simple positive-equals-disease test. It is a probability marker whose meaning depends entirely on your starting odds and whether the standard antibody agrees. Combine a high DGP IgA with a high tTG IgA, and the likelihood of celiac disease climbs sharply. An isolated DGP positive with everything else normal, in a low-risk person, often means nothing.

Tracking a Gluten-Free Diet

Beyond diagnosis, this antibody reflects whether gluten is still reaching your gut. In people already diagnosed with celiac disease, DGP levels track the state of the intestinal lining and can flag ongoing gluten exposure that a food diary misses. The combined IgA-plus-IgG form has been more sensitive than the standard antibody for detecting persistent gut damage on a gluten-free diet in specific assay studies, so follow-up testing sometimes leans on that combination rather than IgA alone. Keep in mind that no antibody test is an accurate stand-alone check of dietary adherence.

Why One Reading Is Not Enough

Antibody levels rise and fall with gluten exposure and gut healing, so a single value is only a snapshot. The trajectory tells you more than any one number. If you have started a gluten-free diet, a level that falls over three to twelve months signals healing, while a plateau or rise points to ongoing gluten reaching the gut.

A practical rhythm is to get a baseline while still eating gluten, retest three to six months after any major dietary change, then at least once a year. Keep in mind that much of the follow-up evidence combines the IgA and IgG forms of the antibody, so pairing this test with its IgG counterpart gives a fuller monitoring picture.

What an Unexpected Result Should Prompt

A positive DGP IgA should never stand alone. The next step is to order the companion markers that put it in context: total IgA (to confirm your body makes enough of this antibody class), tTG IgA, and often the endomysial antibody as a confirmatory test. If the standard tTG antibody is also high, that combination warrants a gastroenterology referral and a discussion of biopsy or a no-biopsy diagnostic pathway.

If DGP IgA is positive but tTG is normal and you are low-risk, the reasonable move is usually to repeat testing while continuing to eat gluten, rather than assuming disease. Genetic testing for the celiac-associated HLA-DQ2 and DQ8 markers can rule the condition out when serology is ambiguous. One thing to avoid: do not start a gluten-free diet before the diagnosis is settled, because doing so can erase the very signal needed to confirm it.

When Results Can Be Misleading

• Already eating gluten-free: this test needs active gluten exposure to produce a meaningful result. On a gluten-free diet, the antibody can normalize and hide underlying disease, so a negative result in that setting does not clear you.
• IgA deficiency: because this is an IgA-class antibody, people whose bodies make very little IgA can test falsely negative. This is exactly why total IgA is checked alongside it, and why an IgG-based test (such as the IgG form of this antibody or tTG IgG) is used instead when IgA is low.
• Low pretest probability: in adults and children without symptoms or risk factors, a positive result is far more likely to be a false alarm than a true signal, which is why it is interpreted against your overall risk.